Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

NCT07639970 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Head and Neck Cancer (H&N)
Pancreatic Cancer
Glioma

Interventions

DRUG: [⁶⁸Ga]Ga-HT547 and [¹⁷⁷Lu]Lu-HT547

Sponsor

Hua Pang